RESMED INC — Director's Dealing 2008

Sep 10, 2008

1Rule 3.19A.2

Appendix 3Y - AMENDED

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity	RMD
ABN	46 064 514 852

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	PETER C. FARRELL
Date of last notice	' August 4, 2008

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.
Date of change	Sept. 2, 2008 (NYSE US dated transaction)
No. of securities held prior to change	Shares 837,054Stock Options 951,200
Class	Common Stock
Number acquired
Number disposed	5000 NYSE shares
Value/ConsiderationNote: If consideration is non-cash, provide details and estimated valuation	US$227,000
No. of securities held after change	Shares 832,672Options 922,582

• See chapter 19 for defined terms.

11/3/2002

Nature of changeExample: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Standing monthly trade pursuant toUSregulation 10b5-1 trading plan.

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relation to which theinterest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation
Interest after change

• See chapter 19 for defined terms.

Appendix 3Y Page 2

RESMED

ResMed Inc

14040 Danielson Street Poway CA 92064-6857

Tel (858) 746 2400 (800) 424 0737 toll free Fax (858) 746 2900

ASX Markets Supervision Pty Ltd. 20 Bridge Street P O Box H224 Sydney Square Sydney NSW 2000 AUSTRALIA

Re: RMD - Amendment of Appendix 3Y Peter Farrell

To Whom it May Concern:

This amendment is lodged in order to correct an error on the Appendix 3Y lodged on September 3, 2008, pursuant to a trade by Peter Farrell, ResMed's Executive Chairman of the Board. The consideration for the September 2, 2008 sale of 5000 shares of RMD was inadvertently omitted. The consideration received was US$227,000.

Also corrected is the number of outstanding ResMed stock options held by Dr. Farrell which currently is 922,582.

Sincerely,

Hitene St. Marki

Arlene Martin Stock Plan Administrator & Risk Manager